Atlas Trials

Post-marketing Surveillance (PMS) to Observe the Safety and Effectiveness of Lyrica CR Extended Release Tablets

Clinical trial NCT04171453 · UNKNOWN

Trial details

NCT number
NCT04171453
Sponsor
Viatris Korea
Status
UNKNOWN
Study type
OBSERVATIONAL
Peripheral Neuropathic Pain
Start date
2020-02-03
Primary completion
2022-07-14
Enrollment
600

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.